Skip to main content

Exousia Bio, Inc.

corporate_fare Company Profile

Exousia Bio, Inc.

LMMY·OTC·Trade & Services·CIK 0001939937

Exousia Bio, Inc. designs, develops, and operates an eLearning and gaming marketplace platform. The company offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. Exousia Bio, Inc. was incorporated in 2022 and is based in New York, New York.

Exousia Bio, Inc. (OTC:LMMY) is a publicly traded company in the Trade & Services sector. Wiseek monitors LMMY SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Exousia Bio (LMMY) Reports Going Concern, Pivots to Biotech, Secures Highly Dilutive $250K Convertible Note, and Rescinds 21M Shares

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$3.75K
Net Income
$51.4K
Diluted EPS
$0.00
Op. Cash Flow
-$4.53K
Gross Profit
-$3.5K
Cash & Equivalents
$0
Net Margin
13.71×
Shares Outstanding
7.78M sh
Source: 10-K · filed 2025-10-17 · accession 0001683168-25-007621
$0.36
52-week range · as of 2026-03-17 $0.06 – $16
Volume
2.5K (1.3× avg)
3-mo avg 2K
Live data · 2026-06-14 08:32 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LMMY - Latest Insights

LMMY
Mar 17, 2026, 1:04 PM EDT
Filing Type: 10-Q
Importance Score:
9
Exousia Bio (LMMY) Reports Going Concern, Pivots to Biotech, Secures Highly Dilutive $250K Convertible Note, and Rescinds 21M Shares
Price at Filing: $0.500
Real-time Price: $0.360 info
Change: -$0.140 (-28%) info
Market Cap: N/A info
Sentiment: Negative
View Wiseek Article